Akebia Therapeutics
AKBA
#7121
Rank
S$0.54 B
Marketcap
$2.48
Share price
2.23%
Change (1 day)
57.29%
Change (1 year)

Akebia Therapeutics (AKBA) - Cash on Hand

Cash on Hand as of September 2024 : S$46.1 Million

According to Akebia Therapeutics's latest financial reports the company has S$46.1 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Akebia Therapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$56.69 M-53.26%
2022-12-31S$0.12 B-40.11%
2021-12-31S$0.20 B-43.03%
2020-12-31S$0.35 B78.52%
2019-12-31S$0.19 B-54.68%
2018-12-31S$0.43 B3.38%
2017-12-31S$0.42 B12.81%
2016-12-31S$0.37 B92.39%
2015-12-31S$0.19 B36.08%
2014-12-31S$0.14 B248.91%
2013-12-31S$41.24 M1955.38%
2012-12-31S$2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$12.21 B 26,388.14%๐Ÿ‡บ๐Ÿ‡ธ USA
S$19.00 B 41,112.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$27.50 B 59,563.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.33 B 618.70%๐Ÿ‡บ๐Ÿ‡ธ USA